Integral Diagnostics Ltd (IDX)

Currency in AUD
2.58
-0.03(-1.15%)
Closed·
IDX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.562.60
52 wk Range
1.913.15
Key Statistics
Bid/Ask
2.55 / 2.62
Prev. Close
2.61
Open
2.58
Day's Range
2.56-2.6
52 wk Range
1.91-3.15
Volume
530.88K
Average Volume (3m)
785.98K
1-Year Change
-12.8378%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
IDX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
3.28
Upside
+27.07%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

Integral Diagnostics Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Integral Diagnostics Ltd Company Profile

Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. The company offers magnetic resonance imaging, positron emission tomography, computed tomography mammography, interventional radiology, ultrasound, and radiography, such as x-ray and EOS. Integral Diagnostics Limited was founded in 1967 and is headquartered in Melbourne, Australia.

Compare IDX to Peers and Sector

Metrics to compare
IDX
Peers
Sector
Relationship
P/E Ratio
205.8x17.7x−0.6x
PEG Ratio
1.97−0.670.00
Price/Book
1.4x1.2x2.6x
Price / LTM Sales
1.5x0.8x3.4x
Upside (Analyst Target)
26.4%16.3%42.0%
Fair Value Upside
Unlock26.6%5.8%Unlock

Analyst Ratings

12 Buy
0 Hold
1 Sell
Ratings:
13 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 3.28
(+27.07% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Goldman Sachs
Sell2.10-18.60%-New CoverageDec 19, 2025
Canaccord Genuity
Buy3.20+24.03%3.40MaintainSep 29, 2025
JPMorgan
Buy3.40+31.78%3.25MaintainAug 27, 2025
RBC Capital
Buy3.45+33.72%3.30MaintainAug 27, 2025
Jefferies
Buy3.50+35.66%3.30MaintainAug 26, 2025

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.02%
Dividend Yield
2.49%
Industry Median 3.52%
Annualized payout
0.07
Paid annually
5-Years Growth
-7.31%
Growth Streak

Earnings

Latest Release
Aug 25, 2025
EPS / Forecast
0.01 / 0.0609
Revenue / Forecast
374.34M / 247.07M
EPS Revisions
Last 90 days

IDX Income Statement

People Also Watch

4.320
DRO
-8.86%
4.830
RMS
+4.77%
6.310
PRU
+3.95%
1.360
EHL
+3.03%

FAQ

What Is the Integral Diagnostics Ltd (IDX) Stock Price Today?

The Integral Diagnostics Ltd stock price today is 2.58

What Stock Exchange Does Integral Diagnostics Ltd Trade On?

Integral Diagnostics Ltd is listed and trades on the Sydney Stock Exchange stock exchange.

What Is the Stock Symbol for Integral Diagnostics Ltd?

The stock symbol for Integral Diagnostics Ltd is "IDX."

Does Integral Diagnostics Ltd Pay Dividends? What’s The Current Dividend Yield?

The Integral Diagnostics Ltd dividend yield is 2.49%.

What Is the Integral Diagnostics Ltd Market Cap?

As of today, Integral Diagnostics Ltd market cap is 957.87M.

What Is Integral Diagnostics Ltd's Earnings Per Share (TTM)?

The Integral Diagnostics Ltd EPS (TTM) is 0.02.

From a Technical Analysis Perspective, Is IDX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Integral Diagnostics Ltd Stock Split?

Integral Diagnostics Ltd has split 1 times.

How Many Employees Does Integral Diagnostics Ltd Have?

Integral Diagnostics Ltd has 3025 employees.

What is the current trading status of Integral Diagnostics Ltd (IDX)?

As of Jan 20, 2026, Integral Diagnostics Ltd (IDX) is trading at a price of 2.58, with a previous close of 2.61. The stock has fluctuated within a day range of 2.56 to 2.60, while its 52-week range spans from 1.91 to 3.15.

What Is Integral Diagnostics Ltd (IDX) Price Target According to Analysts?

The average 12-month price target for Integral Diagnostics Ltd is AUD3.28, with a high estimate of AUD4 and a low estimate of AUD2.1. 12 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +27.07% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.